Example of Open Access Rheumatology: Research and Reviews format
Recent searches

Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format Example of Open Access Rheumatology: Research and Reviews format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Open Access Rheumatology: Research and Reviews — Template for authors

Publisher: Dove Medical Press
Categories Rank Trend in last 3 yrs
Rheumatology #33 of 56 up up by 10 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 120 Published Papers | 345 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 25/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 5.5
SJR: 1.387
SNIP: 2.262
open access Open Access

Springer

Quality:  
High
CiteRatio: 6.6
SJR: 1.393
SNIP: 1.654
open access Open Access

Springer

Quality:  
High
CiteRatio: 4.4
SJR: 1.051
SNIP: 1.315
open access Open Access
recommended Recommended

BMJ Publishing Group

Quality:  
High
CiteRatio: 28.7
SJR: 6.333
SNIP: 4.294

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

2.9

4% from 2019

CiteRatio for Open Access Rheumatology: Research and Reviews from 2016 - 2020
Year Value
2020 2.9
2019 2.8
2018 2.3
2017 0.7
2016 0.5
graph view Graph view
table view Table view

0.63

8% from 2019

SJR for Open Access Rheumatology: Research and Reviews from 2016 - 2020
Year Value
2020 0.63
2019 0.582
2018 0.776
2017 0.445
2016 0.113
graph view Graph view
table view Table view

0.973

8% from 2019

SNIP for Open Access Rheumatology: Research and Reviews from 2016 - 2020
Year Value
2020 0.973
2019 1.063
2018 0.886
2017 0.534
2016 0.159
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 4% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 8% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 8% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Open Access Rheumatology: Research and Reviews

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Dove Medical Press

Open Access Rheumatology: Research and Reviews

Open Access Rheumatology: Research and Reviews is an international, peer-reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheumatology in the clinic and laboratory incl...... Read More

Rheumatology

Medicine

i
Last updated on
25 Jun 2020
i
ISSN
1179-156X
i
Impact Factor
Low - 0.121
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Blue faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. Specular andreev reflection in graphene. Phys. Rev. Lett., 97(6):067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.2147/OARRR.S93516
Anxiety and depression in patients with osteoarthritis: impact and management challenges.
Anirudh Sharma, Prtha Kudesia1, Qian Shi1, Rajiv Gandhi1

Abstract:

Background Anxiety and depression are common psychological comorbidities that impact the quality of life (QoL) of patients In this systematic review, we 1) determined the impact of anxiety and depression on outcomes in patients with osteoarthritis (OA) and 2) summarized unique challenges these comorbidities present to current... Background Anxiety and depression are common psychological comorbidities that impact the quality of life (QoL) of patients In this systematic review, we 1) determined the impact of anxiety and depression on outcomes in patients with osteoarthritis (OA) and 2) summarized unique challenges these comorbidities present to current OA management Patients and methods A systematic literature search was performed using the OVID Medline and EMBASE databases until April 2016 Full-text research articles published in English from the year 2000 onward with a sample size of >100 were included in this review Eligible research articles were reviewed and the following data were extracted: study author(s), year of publication, study design, and key findings Results A total of 38 studies were included in the present review The present study found that both anxiety and/or depression were highly prevalent among patients with OA Patients with OA diagnosed with these comorbidities experienced more pain, had frequent hospital visits, took more medication, and reported less optimal outcomes Management strategies in the form of self-care, telephone support, audio/video education programs, and new pharmacotherapies were reported with favorable results Conclusion Anxiety and depression adversely impact the QoL of patients with OA Physicians/caregivers are highly recommended to consider these comorbidities in patients with OA Ultimately, a holistic individualized management approach is necessary to improve patient outcomes read more read less

Topics:

Anxiety (56%)56% related to the paper, Depression (differential diagnoses) (50%)50% related to the paper
View PDF
138 Citations
open accessOpen access Journal Article DOI: 10.2147/OARRR.S151013
Macrophage activation syndrome: early diagnosis is key.
Butsabong Lerkvaleekul1, Soamarat Vilaiyuk1

Abstract:

Macrophage activation syndrome (MAS) is a life-threatening condition, and it is a subset of hemophagocytic lymphohistiocytosis (HLH) The clinical features include a persistent high-grade fever, hepatosplenomegaly, lymphadenopathy, hemorrhagic manifestations, and a sepsis-like condition From the clinical features, it is usuall... Macrophage activation syndrome (MAS) is a life-threatening condition, and it is a subset of hemophagocytic lymphohistiocytosis (HLH) The clinical features include a persistent high-grade fever, hepatosplenomegaly, lymphadenopathy, hemorrhagic manifestations, and a sepsis-like condition From the clinical features, it is usually difficult to differentiate between a true sepsis, disease flare-ups, or MAS Although the laboratory abnormalities are similar to those of a disseminated intravascular coagulation, which shows pancytopenia, coagulopathy, hypofibrinogenemia, and an elevated d-dimer test, it can also be a late stage of MAS Currently, MAS is still underrecognized and usually results in delayed in diagnosis, which leads to high morbidity and mortality This literature review was conducted in the context of the clinical manifestations and the laboratory abnormalities in MAS, which might provide some clues for an early diagnosis The best ways for an early recognition and a satisfactory diagnosis were based on the relative changes in the overall parameters from the baseline, together with a thorough and continuous physical examination for these kinds of patients At present, diagnostic criteria have been proposed for HLH, MAS-associated systemic juvenile idiopathic arthritis, and an MAS-associated systemic lupus erythematosus Therefore, selecting the proper diagnostic criteria for use is essential because not all of the criteria are suitable for every autoimmune disease read more read less

Topics:

Macrophage activation syndrome (70%)70% related to the paper, Hemophagocytic lymphohistiocytosis (56%)56% related to the paper, Pancytopenia (52%)52% related to the paper, Hepatosplenomegaly (52%)52% related to the paper, Disseminated intravascular coagulation (50%)50% related to the paper
View PDF
78 Citations
open accessOpen access Journal Article DOI: 10.2147/OARRR.S87828
Management of systemic lupus erythematosus during pregnancy: challenges and solutions.

Abstract:

Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease predominantly affecting women, particularly those of childbearing age. SLE provides challenges in the prepregnancy, antenatal, intrapartum, and postpartum periods for these women, and for the medical, obstetric, and midwifery teams who provide the... Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease predominantly affecting women, particularly those of childbearing age. SLE provides challenges in the prepregnancy, antenatal, intrapartum, and postpartum periods for these women, and for the medical, obstetric, and midwifery teams who provide their care. As with many medical conditions in pregnancy, the best maternal and fetal-neonatal outcomes are obtained with a planned pregnancy and a cohesive multidisciplinary approach. Effective prepregnancy risk assessment and counseling includes exploration of factors for poor pregnancy outcome, discussion of risks, and appropriate planning for pregnancy, with consideration of discussion of relative contraindications to pregnancy. In pregnancy, early referral for hospital-coordinated care, involvement of obstetricians and rheumatologists (and other specialists as required), an individual management plan, regular reviews, and early recognition of flares and complications are all important. Women are at risk of lupus flares, worsening renal impairment, onset of or worsening hypertension, preeclampsia, and/or venous thromboembolism, and miscarriage, intrauterine growth restriction, preterm delivery, and/or neonatal lupus syndrome (congenital heart block or neonatal lupus erythematosus). A cesarean section may be required in certain obstetric contexts (such as urgent preterm delivery for maternal and/or fetal well-being), but vaginal birth should be the aim for the majority of women. Postnatally, an ongoing individual management plan remains important, with neonatal management where necessary and rheumatology followup. This article explores the challenges at each stage of pregnancy, discusses the effect of SLE on pregnancy and vice versa, and reviews antirheumatic medications with the latest guidance about their use and safety in pregnancy. Such information is required to effectively and safely manage each stage of pregnancy in women with SLE. read more read less

Topics:

Pregnancy (62%)62% related to the paper, Neonatal lupus erythematosus (60%)60% related to the paper, Miscarriage (59%)59% related to the paper, Systemic lupus erythematosus (51%)51% related to the paper
View PDF
74 Citations
open accessOpen access Journal Article DOI: 10.2147/OARRR.S131668
Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.
Alfonso E. Bello1, Elizabeth L Perkins, Randy Jay, Petros Efthimiou2

Abstract:

Methotrexate (MTX) remains the cornerstone therapy for patients with rheumatoid arthritis (RA), with well-established safety and efficacy profiles and support in international guidelines. Clinical and radiologic results indicate benefits of MTX monotherapy and combination with other agents, yet patients may not receive optima... Methotrexate (MTX) remains the cornerstone therapy for patients with rheumatoid arthritis (RA), with well-established safety and efficacy profiles and support in international guidelines. Clinical and radiologic results indicate benefits of MTX monotherapy and combination with other agents, yet patients may not receive optimal dosing, duration, or route of administration to maximize their response to this drug. This review highlights best practices for MTX use in RA patients. First, to improve the response to oral MTX, a high initial dose should be administered followed by rapid titration. Importantly, this approach does not appear to compromise safety or tolerability for patients. Treatment with oral MTX, with appropriate dose titration, then should be continued for at least 6 months (as long as the patient experiences some response to treatment within 3 months) to achieve an accurate assessment of treatment efficacy. If oral MTX treatment fails due to intolerability or inadequate response, the patient may be "rescued" by switching to subcutaneous delivery of MTX. Consideration should also be given to starting with subcutaneous MTX given its favorable bioavailability and pharmacodynamic profile over oral delivery. Either initiation of subcutaneous MTX therapy or switching from oral to subcutaneous administration improves persistence with treatment. Upon transition from oral to subcutaneous delivery, MTX dosage should be maintained, rather than increased, and titration should be performed as needed. Similarly, if another RA treatment is necessary to control the disease, the MTX dosage and route of administration should be maintained, with titration as needed. read more read less

Topics:

Tolerability (52%)52% related to the paper, Route of administration (51%)51% related to the paper
View PDF
74 Citations
open accessOpen access Journal Article DOI: 10.2147/OARRR.S269889
Psychological state and associated factors during the 2019 coronavirus disease (Covid-19) pandemic among filipinos with rheumatoid arthritis or systemic lupus erythematosus
Cherica A. Tee1, Evelyn O. Salido1, Patrick Wincy C Reyes2, Roger C.M. Ho3, Michael L. Tee1

Abstract:

Background: Patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are perceived to be more vulnerable to worse COVID-19 infection outcome Furthermore, severe shortage in hydroxychloroquine supply was experienced Objective: We presented the psychological responses of Filipino SLE and RA patients to the... Background: Patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are perceived to be more vulnerable to worse COVID-19 infection outcome Furthermore, severe shortage in hydroxychloroquine supply was experienced Objective: We presented the psychological responses of Filipino SLE and RA patients to the COVID-19 pandemic and shortage of hydroxychloroquine supply Methods: A total of 512 completed online surveys from SLE and RA patients were gathered from May 19 to 26, 2020 The online survey collected data on socio-demographics, health status, contact history, health service utilization, use of hydroxychloroquine, COVID-19 knowledge and concerns, precautionary measures, information needs, the validated Impact of Events Scale-Revised (IES-R) and Depression, Anxiety and Stress Scales (DASS-21) ratings Results: The psychological impact of COVID-19 outbreak was at least moderate in 20% The mean IES-R score was higher among SLE (22 34, SD=14 39) than RA (18 85, SD=13 24) patients Stress, anxiety and depression were moderate to severe in 12 3%, 38 7%, and 27 7% of respondents The mean stress subscale score was 10 11 (SD=7 95), mean anxiety subscale score was 6 79 (SD=6 57) and mean depression subscale score was 9 03 (SD=8 77) The risk factors for adverse mental health during the COVID-19 pandemic include the presence of comorbidity of hypertension and asthma;being a healthcare worker;and presence of specific symptoms of myalgia, cough, breathing difficulty, dizziness and sore throat The protective factors for mental health during the pandemic include satisfaction with available health information and wearing of face masks Conclusion: In the third month of the pandemic in the Philippines, 20% of the respondents with lupus and RA experienced moderate to severe psychological impact There was moderate to severe anxiety in 38 7% and moderate to severe depression in 27% Identification of factors that affect mental health in lupus and RA is useful in implementation of effective psychological support strategies © 2020 Tee et al read more read less

Topics:

Hydroxychloroquine (53%)53% related to the paper, Anxiety (53%)53% related to the paper, Mental health (51%)51% related to the paper, Depression (differential diagnoses) (51%)51% related to the paper, Comorbidity (50%)50% related to the paper
View PDF
57 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Open Access Rheumatology: Research and Reviews.

It automatically formats your research paper to Dove Medical Press formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Open Access Rheumatology: Research and Reviews format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Open Access Rheumatology: Research and Reviews in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Open Access Rheumatology: Research and Reviews guidelines and auto format it.

2. Do you follow the Open Access Rheumatology: Research and Reviews guidelines?

Yes, the template is compliant with the Open Access Rheumatology: Research and Reviews guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Open Access Rheumatology: Research and Reviews?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Open Access Rheumatology: Research and Reviews citation style.

4. Can I use the Open Access Rheumatology: Research and Reviews templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Open Access Rheumatology: Research and Reviews.

5. Can I use a manuscript in Open Access Rheumatology: Research and Reviews that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Open Access Rheumatology: Research and Reviews that you can download at the end.

6. How long does it usually take you to format my papers in Open Access Rheumatology: Research and Reviews?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Open Access Rheumatology: Research and Reviews.

7. Where can I find the template for the Open Access Rheumatology: Research and Reviews?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Open Access Rheumatology: Research and Reviews's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Open Access Rheumatology: Research and Reviews's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Open Access Rheumatology: Research and Reviews an online tool or is there a desktop version?

SciSpace's Open Access Rheumatology: Research and Reviews is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Open Access Rheumatology: Research and Reviews?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Open Access Rheumatology: Research and Reviews?”

11. What is the output that I would get after using Open Access Rheumatology: Research and Reviews?

After writing your paper autoformatting in Open Access Rheumatology: Research and Reviews, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Open Access Rheumatology: Research and Reviews's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Open Access Rheumatology: Research and Reviews?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Open Access Rheumatology: Research and Reviews. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Open Access Rheumatology: Research and Reviews?

The 5 most common citation types in order of usage for Open Access Rheumatology: Research and Reviews are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Open Access Rheumatology: Research and Reviews?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Open Access Rheumatology: Research and Reviews's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Open Access Rheumatology: Research and Reviews in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Open Access Rheumatology: Research and Reviews Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Open Access Rheumatology: Research and Reviews formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template